Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 17, 2016
Total Value: $664M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALDER BIOPHARMACEUTICALS INC | 1,497,475 | $36.67M | 5.5% | $32.92 | — | COM | 014339105 |
| HRTX | HERON THERAPEUTICS INC | 1,750,000 | $33.23M | 5.0% | $15.68 | +25.8% | COM | 427746102 |
| — | SAGE THERAPEUTICS INC | 945,000 | $30.3M | 4.6% | $36.75 | — | COM | 78667J108 |
| OMER | OMEROS CORP | 1,960,000 | $30.07M | 4.5% | $15.02 | -19.1% | COM | 682143102 |
| — | NEKTAR THERAPEUTICS | 2,000,000 | $27.5M | 4.1% | $13.99 | — | COM | 640268108 |
| — | NEVRO CORP | 485,386 | $27.31M | 4.1% | $53.76 | — | COM | 64157F103 |
| ALKS | ALKERMES PLC | 700,000 | $23.93M | 3.6% | $56.67 | -30.3% | SHS | G01767105 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 603,900 | $23.88M | 3.6% | $15.30 | +159.4% | COM | 64125C109 |
| EGRX | EAGLE PHARMACEUTICALS INC | 500,000 | $20.25M | 3.1% | $40.55 | +56.5% | COM | 269796108 |
| — | DYNAVAX TECHNOLOGIES CORP | 975,000 | $18.76M | 2.8% | $21.79 | — | COM NEW | 268158201 |
| — | PROTEOSTASIS THERAPEUTICS IN | 1,726,599 | $16.64M | 2.5% | $9.64 | — | COM | 74373B109 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 245,000 | $15.38M | 2.3% | $108.02 | -38.5% | COM | 02043Q107 |
| — | PORTOLA PHARMACEUTICALS INC | 700,000 | $14.28M | 2.2% | $25.47 | — | COM | 737010108 |
| — | QUOTIENT LTD | 1,519,100 | $13.37M | 2.0% | $14.29 | — | SHS | G73268107 |
| MGNX | MACROGENICS INC | 700,000 | $13.13M | 2.0% | $27.14 | -29.8% | COM | 556099109 |
| CLLS | CELLECTIS S A | 469,145 | $12.9M | 1.9% | $31.12 | — | SPONSORED ADS | 15117K103 |
| — | TESARO INC | 291,250 | $12.82M | 1.9% | $38.73 | — | COM | 881569107 |
| — | CHINA BIOLOGIC PRODS INC | 111,500 | $12.77M | 1.9% | $66.66 | — | COM | 16938C106 |
| ACRS | ACLARIS THERAPEUTICS INC COM | 647,944 | $12.28M | 1.8% | $19.34 | -1.2% | COM | 00461U105 |
| CHRS | COHERUS BIOSCIENCES INC | 569,130 | $12.08M | 1.8% | $20.98 | -21.9% | COM | 19249H103 |
| ARDX | ARDELYX INC | 1,481,075 | $11.51M | 1.7% | $17.63 | -44.2% | COM | 039697107 |
| — | VITAE PHARMACEUTICALS INC | 1,735,000 | $11.5M | 1.7% | $10.75 | — | COM | 92847N103 |
| SRNE | SORRENTO THERAPEUTICS INC | 2,095,334 | $11.27M | 1.7% | $9.16 | -36.5% | COM NEW | 83587F202 |
| — | MINERVA NEUROSCIENCES INC | 1,752,946 | $10.76M | 1.6% | $5.50 | — | COM | 603380106 |
| — | MIRATI THERAPEUTICS INC | 495,356 | $10.6M | 1.6% | $33.05 | — | COM | 60468T105 |
| DXCM | DEXCOM INC | 153,000 | $10.39M | 1.6% | $7.91 | +111.1% | COM | 252131107 |
| — | CELGENE CORP | 100,000 | $10.01M | 1.5% | $100.09 | — | COM | 151020104 |
| — | ROCKWELL MEDICAL INC | 1,105,000 | $8.299M | 1.3% | $9.23 | — | COM | 774374102 |
| — | NOVAVAX INC | 1,600,000 | $8.256M | 1.2% | $6.35 | — | COM | 670002104 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 450,000 | $8.168M | 1.2% | $17.29 | +5.1% | COM | 19459J104 |
| — | MYOKARDIA INC | 753,388 | $8.069M | 1.2% | $14.66 | — | COM | 62857M105 |
| — | ADVAXIS INC | 800,000 | $7.224M | 1.1% | $7.24 | — | COM NEW | 007624208 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 109,500 | $6.932M | 1.0% | $50.99 | +28.3% | COM | 90400D108 |
| — | CELATOR PHARMACEUTICALS INC | 620,000 | $6.839M | 1.0% | $11.03 | — | COM | 15089R102 |
| — | LIPOCINE INC NEW | 666,666 | $6.767M | 1.0% | $6.90 | — | COM | 53630X104 |
| — | SERES THERAPEUTICS INC | 250,000 | $6.64M | 1.0% | $32.01 | — | COM | 81750R102 |
| — | AGENUS INC | 1,559,000 | $6.485M | 1.0% | $4.54 | — | COM NEW | 00847G705 |
| — | PFENEX INC | 624,900 | $6.143M | 0.9% | $16.77 | — | COM | 717071104 |
| — | FORWARD PHARMA A/S | 335,068 | $5.696M | 0.9% | $23.83 | — | SPONSORED ADR | 34986J105 |
| WVE | WAVE LIFE SCIENCES LTD | 392,079 | $5.442M | 0.8% | $15.68 | -10.8% | SHS | Y95308105 |
| — | ACCELERON PHARMA INC | 200,000 | $5.278M | 0.8% | $32.04 | — | COM | 00434H108 |
| CTMX | CYTOMX THERAPEUTICS INC | 371,023 | $4.786M | 0.7% | $15.82 | -12.2% | COM | 23284F105 |
| — | RECRO PHARMA INC | 780,000 | $4.657M | 0.7% | $7.16 | — | COM | 75629F109 |
| — | ZYNERBA PHARMACEUTICALS INC | 475,035 | $4.489M | 0.7% | $13.10 | — | COM | 98986X109 |
| — | ACHILLION PHARMACEUTICALS IN | 500,000 | $3.86M | 0.6% | $10.79 | — | COM | 00448Q201 |
| — | DERMIRA INC | 170,000 | $3.516M | 0.5% | $18.11 | — | COM | 24983L104 |
| — | AGILE THERAPEUTICS INC | 557,053 | $3.459M | 0.5% | $7.06 | — | COM | 00847L100 |
| — | CELYAD SA | 75,000 | $3.312M | 0.5% | $52.03 | — | ADR | 151205200 |
| — | INTEC PHARMA LTD JERUSALEM | 800,000 | $3.296M | 0.5% | $5.60 | — | SHS | M53644106 |
| — | EPIZYME INC | 266,250 | $3.227M | 0.5% | $18.78 | — | COM | 29428V104 |
| — | APTOSE BIOSCIENCES INC | 1,081,867 | $3.179M | 0.5% | $5.91 | — | COM NEW | 03835T200 |
| — | KITE PHARMA INC | 68,800 | $3.159M | 0.5% | $46.23 | — | COM | 49803L109 |
| BCRX | BIOCRYST PHARMACEUTICALS | 1,080,000 | $3.056M | 0.5% | $11.03 | -59.8% | COM | 09058V103 |
| SNDX | SYNDAX PHARMACEUTICALS INC. | 214,419 | $2.856M | 0.4% | $12.54 | 0.0% | COM | 87164F105 |
| — | ATARA BIOTHERAPEUTICS INC | 150,000 | $2.855M | 0.4% | $38.55 | — | COM | 046513107 |
| — | CONTRAFECT CORP | 834,406 | $2.837M | 0.4% | $3.92 | — | COM | 212326102 |
| — | BELLICUM PHARMACEUTICALS INC | 300,000 | $2.805M | 0.4% | $20.27 | — | COM | 079481107 |
| — | LION BIOTECHNOLOGIES INC | 499,815 | $2.539M | 0.4% | $11.67 | — | COM | 53619R102 |
| — | IMMUNE DESIGN CORP | 189,000 | $2.457M | 0.4% | $18.77 | — | COM | 45252L103 |
| — | EPIRUS BIOPHARMACEUTICALS IN | 896,600 | $2.412M | 0.4% | $8.68 | — | COM | 29428P107 |
| — | OVASCIENCE INC | 252,180 | $2.393M | 0.4% | $25.13 | — | COM | 69014Q101 |
| — | CURIS INC | 1,162,400 | $1.871M | 0.3% | $2.28 | — | COM | 231269101 |
| RGNX | REGENXBIO INC | 156,741 | $1.693M | 0.3% | $25.52 | -49.9% | COM | 75901B107 |
| — | GLYCOMIMETICS INC | 283,555 | $1.69M | 0.3% | $16.33 | — | COM | 38000Q102 |
| — | AQUINOX PHARMACEUTICALS INC | 150,000 | $1.323M | 0.2% | $12.15 | — | COM | 03842B101 |
| — | BIOTIE THERAPIES OYJ | 50,000 | $1.32M | 0.2% | $19.98 | — | SPONSORED ADR | 09074D103 |
| FOLD | AMICUS THERAPEUTICS INC | 150,000 | $1.268M | 0.2% | $12.02 | -41.1% | COM | 03152W109 |
| — | TETRALOGIC PHARMACEUTICALS C | 5,000,000 | $1.15M | 0.2% | $0.60 | — | NOTE 8.000% 6/1 | 88165UAB5 |
| ASND | ASCENDIS PHARMA A S | 61,500 | $1.141M | 0.2% | $17.35 | — | SPONSORED ADR | 04351P101 |
| — | AVEO PHARMACEUTICALS INC | 1,087,715 | $1.001M | 0.2% | $1.74 | — | COM | 053588109 |
| — | GENVEC INC | 1,176,235 | $948K | 0.1% | $2.65 | — | COM NEW | 37246C307 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $836K | 0.1% | $0.82 | -49.5% | COM | 74373P108 |
| VCYT | VERACYTE INC | 137,990 | $745K | 0.1% | $7.94 | -25.6% | COM | 92337F107 |
| — | NANOSTRING TECHNOLOGIES INC | 40,000 | $609K | 0.1% | $20.65 | — | COM | 63009R109 |
| — | HTG MOLECULAR DIAGNOSTICS IN | 201,000 | $577K | 0.1% | $11.15 | — | COM | 40434H104 |
| — | NEOS THERAPEUTICS INC | 50,000 | $540K | 0.1% | $21.02 | — | COM | 64052L106 |
| — | THRESHOLD PHARMACEUTICALS INC | 1,000,000 | $460K | 0.1% | $0.48 | — | COM NEW | 885807206 |
| — | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $440K | 0.1% | $0.22 | — | *W EXP 06/19/202 | 74373P116 |
| — | PRONAI THERAPEUTICS INC | 53,153 | $358K | 0.1% | $20.53 | — | COM | 74346L101 |
| — | APPLIED GENETIC TECHNOL CORP | 17,110 | $239K | 0.0% | $23.10 | — | COM | 03820J100 |
| — | REGULUS THERAPEUTICS INC | 30,656 | $212K | 0.0% | $14.62 | — | COM | 75915K101 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 25,000 | $203K | 0.0% | $18.32 | — | SPONDS ADR | 00653A107 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $180K | 0.0% | $3.40 | — | COM | 15117F302 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $38,000 | 0.0% | $0.60 | — | *W EXP 08/19/201 | 15117F112 |